Fondaparinux Trial With Unfractionated Heparin (UFH) During Revascularization in Acute Coronary Syndromes (ACS)

Clinical trial NCT00790907 · COMPLETED

Trial details

NCT number: NCT00790907
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Acute Coronary Syndrome

Start date: 2009-02-01
Primary completion: 2010-05-01
Enrollment: 3235

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.